Amgen Inc Stock Price History
| AMGN Stock | USD 319.66 2.18 0.69% |
Below is the normalized historical share price chart for Amgen Inc extending back to June 17, 1983. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Amgen stands at 319.66, as last reported on the 4th of October, with the highest price reaching 320.74 and the lowest price hitting 316.43 during the day.
If you're considering investing in Amgen Stock, it is important to understand the factors that can impact its price. As of now, Amgen Stock is very steady. Amgen Inc secures Sharpe Ratio (or Efficiency) of 0.0355, which signifies that the company had a 0.0355% return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for Amgen Inc, which you can use to evaluate the volatility of the firm. Please confirm Amgen's risk adjusted performance of 0.0345, and Mean Deviation of 0.9648 to double-check if the risk estimate we provide is consistent with the expected return of 0.051%.
At this time, Amgen's Total Stockholder Equity is very stable compared to the past year. As of the 4th of October 2024, Common Stock Shares Outstanding is likely to grow to about 759.2 M, while Common Stock Total Equity is likely to drop about 27.1 B. . At this time, Amgen's Price Cash Flow Ratio is very stable compared to the past year. As of the 4th of October 2024, Price Sales Ratio is likely to grow to 9.47, while Price Earnings Ratio is likely to drop 21.79. Amgen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of June 1983 | 200 Day MA 303.9458 | 50 Day MA 327.589 | Beta 0.602 |
Amgen |
Sharpe Ratio = 0.0355
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | AMGN | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.44 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Amgen is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amgen by adding it to a well-diversified portfolio.
Price Book 28.7909 | Enterprise Value Ebitda 18.9594 | Price Sales 5.5147 | Shares Float 535.8 M | Dividend Share 8.76 |
Amgen Stock Price History Chart
There are several ways to analyze Amgen Stock price data. The simplest method is using a basic Amgen candlestick price chart, which shows Amgen price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 20, 2024 | 337.38 |
| Lowest Price | August 7, 2024 | 310.34 |
Amgen October 4, 2024 Stock Price Synopsis
Various analyses of Amgen's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Amgen Stock. It can be used to describe the percentage change in the price of Amgen from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Amgen Stock.| Amgen Accumulation Distribution | 19,724 | |
| Amgen Price Rate Of Daily Change | 1.01 | |
| Amgen Price Daily Balance Of Power | 0.51 | |
| Amgen Price Action Indicator | 2.17 |
Amgen October 4, 2024 Stock Price Analysis
Amgen Stock Price History Data
The price series of Amgen for the period between Sat, Jul 6, 2024 and Fri, Oct 4, 2024 has a statistical range of 30.14 with a coefficient of variation of 2.27. The prices are distributed with arithmetic mean of 325.9. The median price for the last 90 days is 328.55. The company had 2:1 stock split on 22nd of November 1999. Amgen Inc issued dividends on 2024-08-16.| Open | High | Low | Close | Volume | ||
| 10/04/2024 | 318.72 | 320.74 | 316.43 | 319.66 | 1,467,828 | |
| 10/03/2024 | 317.11 | 319.73 | 315.46 | 317.48 | 1,524,966 | |
| 10/02/2024 | 317.63 | 320.67 | 316.18 | 319.73 | 2,614,363 | |
| 10/01/2024 | 322.05 | 322.20 | 316.92 | 320.32 | 2,097,358 | |
| 09/30/2024 | 321.32 | 323.23 | 318.79 | 322.21 | 1,966,981 | |
| 09/27/2024 | 322.70 | 327.98 | 320.52 | 322.67 | 2,432,589 | |
| 09/26/2024 | 313.68 | 319.78 | 313.37 | 319.10 | 2,555,301 | |
| 09/25/2024 | 329.00 | 329.50 | 312.16 | 312.86 | 4,247,896 | |
| 09/24/2024 | 333.15 | 335.41 | 330.50 | 330.92 | 2,100,258 | |
| 09/23/2024 | 339.00 | 339.17 | 333.36 | 335.61 | 1,677,561 | |
| 09/20/2024 | 335.15 | 338.97 | 334.27 | 337.38 | 4,067,852 | |
| 09/19/2024 | 337.03 | 338.70 | 334.61 | 335.95 | 1,626,214 | |
| 09/18/2024 | 333.93 | 339.00 | 331.00 | 332.92 | 1,366,586 | |
| 09/17/2024 | 334.58 | 334.58 | 331.08 | 332.80 | 2,014,003 | |
| 09/16/2024 | 335.84 | 337.56 | 332.92 | 335.26 | 2,360,565 | |
| 09/13/2024 | 327.96 | 334.45 | 327.15 | 332.45 | 1,397,002 | |
| 09/12/2024 | 330.22 | 332.38 | 326.41 | 330.06 | 1,590,175 | |
| 09/11/2024 | 327.81 | 330.65 | 320.30 | 329.98 | 1,711,019 | |
| 09/10/2024 | 327.00 | 329.23 | 322.39 | 328.93 | 1,408,587 | |
| 09/09/2024 | 322.52 | 327.81 | 320.10 | 325.92 | 1,706,717 | |
| 09/06/2024 | 324.70 | 326.97 | 319.00 | 320.56 | 2,242,416 | |
| 09/05/2024 | 330.90 | 331.86 | 321.91 | 324.36 | 1,976,410 | |
| 09/04/2024 | 329.93 | 331.10 | 327.60 | 330.64 | 1,621,618 | |
| 09/03/2024 | 331.89 | 333.14 | 329.10 | 330.51 | 2,120,509 | |
| 08/30/2024 | 331.95 | 335.66 | 330.31 | 333.83 | 2,173,473 | |
| 08/29/2024 | 331.67 | 334.27 | 329.25 | 331.01 | 1,294,254 | |
| 08/28/2024 | 325.94 | 330.51 | 325.39 | 329.49 | 1,444,092 | |
| 08/27/2024 | 328.42 | 329.83 | 325.58 | 326.93 | 1,444,346 | |
| 08/26/2024 | 328.41 | 330.26 | 325.50 | 326.78 | 1,769,925 | |
| 08/23/2024 | 326.27 | 331.12 | 325.38 | 328.80 | 1,766,008 | |
| 08/22/2024 | 329.50 | 329.50 | 323.20 | 324.53 | 2,171,905 | |
| 08/21/2024 | 329.55 | 330.99 | 327.91 | 329.15 | 1,138,146 | |
| 08/20/2024 | 328.25 | 330.48 | 326.62 | 328.55 | 1,350,896 | |
| 08/19/2024 | 321.46 | 328.15 | 321.41 | 327.97 | 1,213,946 | |
| 08/16/2024 | 323.65 | 324.82 | 320.50 | 321.44 | 1,429,982 | |
| 08/15/2024 | 321.64 | 324.90 | 319.71 | 323.14 | 1,886,800 | |
| 08/14/2024 | 318.21 | 322.12 | 317.35 | 320.50 | 1,656,100 | |
| 08/13/2024 | 319.55 | 321.76 | 316.96 | 321.21 | 1,632,800 | |
| 08/12/2024 | 321.66 | 321.66 | 315.73 | 317.79 | 1,828,700 | |
| 08/09/2024 | 321.51 | 322.79 | 317.12 | 320.26 | 1,786,400 | |
| 08/08/2024 | 311.83 | 322.87 | 310.63 | 322.44 | 2,746,700 | |
| 08/07/2024 | 318.77 | 320.77 | 304.47 | 310.34 | 4,618,400 | |
| 08/06/2024 | 322.98 | 330.68 | 321.28 | 326.68 | 2,436,500 | |
| 08/05/2024 | 330.42 | 331.04 | 319.19 | 322.97 | 2,974,900 | |
| 08/02/2024 | 335.09 | 336.01 | 323.48 | 331.68 | 2,106,200 | |
| 08/01/2024 | 333.77 | 338.53 | 331.15 | 333.21 | 2,387,700 | |
| 07/31/2024 | 329.26 | 334.08 | 328.28 | 330.17 | 2,120,500 | |
| 07/30/2024 | 330.70 | 336.23 | 329.38 | 330.98 | 1,584,000 | |
| 07/29/2024 | 331.77 | 332.52 | 329.01 | 330.21 | 1,611,200 | |
| 07/26/2024 | 332.25 | 336.60 | 330.98 | 332.53 | 1,515,500 | |
| 07/25/2024 | 333.67 | 344.45 | 330.72 | 331.99 | 2,435,700 | |
| 07/24/2024 | 330.95 | 334.85 | 328.06 | 333.29 | 2,459,300 | |
| 07/23/2024 | 332.05 | 334.71 | 329.02 | 330.94 | 1,458,200 | |
| 07/22/2024 | 330.93 | 334.76 | 330.17 | 333.65 | 1,733,700 | |
| 07/19/2024 | 331.34 | 331.67 | 326.16 | 329.00 | 1,848,700 | |
| 07/18/2024 | 331.89 | 336.64 | 328.38 | 328.68 | 2,228,400 | |
| 07/17/2024 | 327.72 | 334.28 | 326.33 | 333.35 | 1,933,200 | |
| 07/16/2024 | 328.17 | 333.59 | 325.73 | 330.84 | 1,879,400 | |
| 07/15/2024 | 329.59 | 330.51 | 325.60 | 327.87 | 1,688,800 | |
| 07/12/2024 | 325.55 | 331.54 | 323.76 | 328.54 | 2,191,300 | |
| 07/11/2024 | 319.77 | 325.72 | 317.97 | 322.84 | 2,254,000 |
About Amgen Stock history
Amgen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Amgen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Amgen Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Amgen stock prices may prove useful in developing a viable investing in Amgen
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 538 M | 759.2 M | |
| Net Income Applicable To Common Shares | 7.5 B | 5 B |
Amgen Quarterly Net Working Capital |
|
Amgen Stock Technical Analysis
Amgen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Amgen Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Amgen's price direction in advance. Along with the technical and fundamental analysis of Amgen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Amgen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0345 | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0426 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Information and Resources on Investing in Amgen Stock
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.46) | Dividend Share 8.76 | Earnings Share 5.81 | Revenue Per Share 57.659 | Quarterly Revenue Growth 0.201 |
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.